A scientific statement regarding HF with preserved ejection fraction in patients with cancer and cancer survivors has been published by the ESC.

Compared with just a few years ago, medical treatment options for HF with preserved ejection fraction have expanded greatly, culminating in the first useful new agent for the HFpEF population. The ...

HF with preserved ejection fraction is recognized as a major contributor to CV morbidity and mortality and a growing health problem worldwide. The prevalence of HF with preserved EF (HFpEF) is ...

Serum fatty acid–binding protein 4 levels were increased in patients with heart failure with preserved ejection fraction (HFpEF), associated with cardiac remodeling and dysfunction, and linked to poor ...

—A recent study used transcriptomic analysis to identify specific clinical features of HFpEF, with the ultimate goal of introducing improved, personalized therapies. A transcriptome analysis has ...

Among patients with heart failure with preserved ejection fraction (HFpEF), lower versus higher ranges of EF signal fundamentally different morphologies and hemodynamic responses, which may have ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jennifer E. Ho, MD ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Today we'll take a ...

Javed Butler, MD, MPH, MBA, discusses the additional benefits of combining finerenone with sodium-glucose cotransporter-2 inhibitors for treating heart failure (HF) with midrange ejection fraction (EF ...

A new analysis of the EMPEROR-Preserved trial sheds light on the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance; Boehringer Ingelheim/Eli Lilly) in patients ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CLEVELAND -- ...

Heart failure with preserved ejection fraction (HFpEF) is a common condition, affecting millions of people and resulting in significant illness and death. No effective treatments have been developed ...